Endocrine Abstracts

It was reported that outpatients with type 1 diabetes using real-time continuous glucose monitoring (rtCGM) reduce HbA1c more than those using self-monitoring of blood glucose (SMBG). However, it is not well known whether inpatients with type 2 diabetes using rtCGM reduce glycemic variability more than those using SMBG. This is a prospective parallel-group comparative study. Sixteen patients with type 2 diabetes hospitalized for diabetes treatment were randomly allocated to 2 ...

We evaluated the relationship between blood glucose and urine glucose levels in type 2 diabetes (T2D) patients who had reached steady state upon taking a sodium-glucose co-transporter-2 inhibitor (SGLT-2 inhibitor). Ten patients with T2D taking Luseogliflozin 2.5 mg for more than 2 weeks were hospitalized for diabetes treatment. During hospitalization, the patients used a continuous glucose monitor (CGM) [iPro2] for 6 days (CGM attachment: day 1) while continuing Luseogliflozi...

We studied regarding simplifying standard deviation (SD) and useful metrics for achieving target SD. In a cross-sectional study, we analyzed 24-h glucose levels measured using continuous glucose monitor (CGM) [iPro2] in 150 patients with type 2 diabetes. We analyzed 51 time in range (TIR) (reference ranges: mean glucose level (M)±20, M±21 … M±69, M±70 mg/dl [we referred to the underlined numbers as “Margin”]). We analyzed optimal cutoff values of TI...

The mean absolute relative difference (MARD) on CGM was reported with the various values approximately from 5% to 10%. The MARD in patients with type 1 diabetes was reported to be higher than that in patients with type 2 diabetes. Therefore, as one of the reasons why the reported MARD values varied, it cannot be denied that glycemic variability affects calibration accuracy. We examined relationships between calibration accuracy and glycemic variability on CGM. This is a prospe...

There is little information regarding inter-individual variability of accuracy for CGM and flash glucose monitor (FGM) sensors. We studied the possibility of inter-individual variability of accuracy for CGM and FGM sensors. This is a prospective study. During hospitalization, 10 patients with type 2 diabetes wore a CGM [iPro2] and FGM [FreeStyle Libre Pro] in parallel over 24 h while every pre- and post-prandial “venous blood glucose levels” (VBG) were measured and u...

TCV, % 15.0 16.0 17.0 18.0 19.0 20.0 21.0 22.0 23.0 24.0 25.0 26.0 27.0 PO, % 20.0 23.0 28.0 30.0 31.0 29.0 29.0 31.0 ...